Form 4 for CNSP CNS Pharmaceuticals, Inc.
Accepted 2023-04-18 00:00:00 ET · period of report 2023-04-17 · accession 0001683168-23-002495 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-18 | 2023-04-17 | CNSP | Downs Christopher | CFO | P - Purchase | $3.20 | +3,100 | 9,251 | +50% | +$9,920 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-17 | P | A | 3,100 | $3.20 | 9,251 | D | — | — |